PTH increases jaw mineral density in a rabbit model of osteoporosis.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 20177133)

Published in J Dent Res on February 22, 2010

Authors

M Bellido1, L Lugo, S Castañeda, J A Roman-Blas, J A Rufián-Henares, M Navarro-Alarcón, R Largo, G Herrero-Beaumont

Author Affiliations

1: Bone and Joint Research Unit, Service of Rheumatology, Fundación Jiménez Díaz, Universidad Autónoma, Av. Reyes Católicos 2, 28040-Madrid, Spain.

Articles by these authors

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2003) 7.95

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2004) 4.94

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 2.75

Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.66

A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis (2011) 2.24

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis (2009) 1.95

Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage (2003) 1.79

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int (2001) 1.50

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol (2001) 1.42

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Ann Rheum Dis (2004) 1.28

Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage (2006) 1.19

Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthritis Cartilage (2004) 1.18

Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage (2011) 1.13

Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits. Skeletal Radiol (2005) 1.12

High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthritis Cartilage (2001) 1.11

A sonographic enthesitic index of lower limbs is a valuable tool in the assessment of ankylosing spondylitis. Ann Rheum Dis (2006) 1.09

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis Cartilage (2005) 1.08

Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension (1996) 1.07

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis (2004) 1.03

Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers. Blood (1976) 0.99

Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response. J Lipid Mediat (1990) 0.99

ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int (1995) 0.98

Effects of ritanserin on sleep disturbances of dysthymic patients. Psychopharmacology (Berl) (1988) 0.98

Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension (2001) 0.97

A method for determining the dynamics and intensity of average growth. Ann Hum Biol (1991) 0.96

Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis (2006) 0.95

Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol (2008) 0.95

Early pattern recognition in severe perinatal asphyxia: a prospective MRI study. Neuroradiology (1993) 0.95

[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]. Actas Dermosifiliogr (2012) 0.95

A fibrin based model for rheumatoid synovitis. Ann Rheum Dis (2003) 0.93

An analysis of the mid-growth and adolescent spurts of height based on acceleration. Ann Hum Biol (1985) 0.92

Compensatory maturational deceleration of growth or "catch-down growth" in patients with congenital adrenal hyperplasia after delayed initiation of therapy. Eur J Pediatr (1986) 0.92

Fibrin generated in the synovial fluid activates intimal cells from their apical surface: a sequential morphological study in antigen-induced arthritis. Rheumatology (Oxford) (2003) 0.91

Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast--comparison to its effects on osteoarthritic chondrocytes. Rheumatology (Oxford) (2008) 0.91

Urine arsenic concentrations in healthy adults as indicators of environmental contamination: relation with some pathologies. Sci Total Environ (1998) 0.90

Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis. Ann Rheum Dis (2008) 0.90

Correlation between arthroscopic and histopathological grading systems of articular cartilage lesions in knee osteoarthritis. Osteoarthritis Cartilage (2008) 0.89

Effects of an exercise program on the rehabilitation of patients with spinal cord injury. Arch Phys Med Rehabil (2001) 0.88

EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts. Ann Rheum Dis (2004) 0.88

Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. Osteoarthritis Cartilage (2008) 0.87

Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann Rheum Dis (2002) 0.87

Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Am Soc Nephrol (1997) 0.87

Cyclosporin A prevents the histologic damage of antigen arthritis without inducing fibrosis. Arthritis Rheum (2000) 0.86

Biochemical markers of bone remodeling and bone sialoprotein in ankylosing spondylitis. Clin Chim Acta (1999) 0.86

Chondroitin sulfate improves synovitis in rabbits with chronic antigen-induced arthritis. Osteoarthritis Cartilage (2010) 0.86

An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int (1996) 0.85

Zinc and copper concentrations in serum from Spanish women during pregnancy. Biol Trace Elem Res (1998) 0.85

Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells. Clin Exp Immunol (1998) 0.84

Velocity and acceleration of height growth using kernel estimation. Ann Hum Biol (1984) 0.84

Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 0.84

Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits. Clin Exp Immunol (1992) 0.84

Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol (2012) 0.84

[Relationship between methylenetetrahydrofolate reductase polymorphism and homocysteine levels in women with recurrent pregnancy loss: a nutrigenetic perspective]. Nutr Hosp (2008) 0.83

Commentary: osteoarthritis of the knee and glucosamine. Osteoarthritis Cartilage (2006) 0.83

Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. J Lipid Mediat Cell Signal (1996) 0.83

Endothelin-1 expression during early response after antigen challenge in brown-norway rats. Pulm Pharmacol Ther (1999) 0.83

The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis. Tissue Antigens (2013) 0.83

Expression of the peptide C4b-binding protein beta in the arthritic joint. Ann Rheum Dis (2006) 0.82

SAMe restores the changes in the proliferation and in the synthesis of fibronectin and proteoglycans induced by tumour necrosis factor alpha on cultured rabbit synovial cells. Br J Rheumatol (1997) 0.82

Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions (1994) 0.82

Serum copper and zinc concentrations in serum from patients with cancer and cardiovascular disease. Sci Total Environ (1997) 0.82

Differences between radiographic abnormalities of acromegalic arthropathy and those of osteoarthritis. Arthritis Rheum (1990) 0.81

Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration. Arthritis Res Ther (2013) 0.81

Sequential changes of parathyroid hormone related protein (PTHrP) in articular cartilage during progression of inflammatory and degenerative arthritis. Ann Rheum Dis (2004) 0.81

Serum zinc and copper concentrations and Cu/Zn ratios in patients with hepatopathies or diabetes. J Trace Elem Med Biol (1998) 0.81

Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease. Br J Haematol (1974) 0.81

Protein losing enteropathy as the initial manifestation of systemic lupus erythematosus. J Rheumatol (1985) 0.81

Up-regulation of parathyroid hormone-related protein in folic acid-induced acute renal failure. Kidney Int (2001) 0.81

Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.81

Measures of body mass and of obesity from infancy to adulthood and their appropriate transformation. Ann Hum Biol (1994) 0.80

Prevalence of spondyloarthritis in Terceira, Azores: a population based study. Ann Rheum Dis (2002) 0.79

Massive pulmonary hemorrhage: fatal complication of systemic lupus erythematosus. J Rheumatol (1985) 0.79

Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis. Clin Exp Rheumatol (2007) 0.79

Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultured rabbit synovial cells. Eur J Pharmacol (1996) 0.79

Polymyalgia rheumatica in the young female as a syndrome of presentation of Takayasu's arteritis. Clin Exp Rheumatol (1996) 0.79

An experimental study of COMP (cartilage oligomeric matrix protein) in the rabbit menisci. Arch Orthop Trauma Surg (2011) 0.79